Legato Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,739
Closed -$688K 896
2025
Q4
$688K Buy
+27,739
New +$737K 0.06% 463
2024
Q4
Sell
-5,902
Closed -$342K 624
2024
Q3
$342K Buy
+5,902
New +$290K 0.04% 492
2021
Q3
Sell
-10,359
Closed -$651K 326
2021
Q2
$651K Buy
+10,359
New +$383K 0.09% 214

Other funds holding ASTH

Legato Capital Management's ASTH Position: Q1 2026 in Review

Legato Capital Management sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 27,739 shares — an estimated $688K sold.

Legato Capital Management first reported a position in ASTH in Q2 2021 and held it in 3 quarters. The position peaked at $688K in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Legato Capital Management reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
  • Legato Capital Management sold 27,739 Astrana Health shares in Q1 2026, an estimated $688K.
  • Legato Capital Management first reported a position in Astrana Health in Q2 2021 and held it in 3 quarters.
  • Legato Capital Management's Astrana Health position peaked at $688K in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.